These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16222837)

  • 1. Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices.
    Mathews AW
    Wall St J (East Ed); 2005 Aug; ():A1, A6. PubMed ID: 16222837
    [No Abstract]   [Full Text] [Related]  

  • 2. The formulary files. Step therapy for antidepressants saves 11.7 percent in one year.
    Manag Care; 2006 Nov; 15(11):59. PubMed ID: 17168073
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives. Drug formularies pose legal threat to providers.
    Moskowitz DB
    Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
    [No Abstract]   [Full Text] [Related]  

  • 4. Data watch. Is this the way to manage pharmacy costs?
    Bus Health; 1997 Sep; 15(9):94. PubMed ID: 10173238
    [No Abstract]   [Full Text] [Related]  

  • 5. As drug costs rise, health plans shift the burden.
    Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
    [No Abstract]   [Full Text] [Related]  

  • 6. Insurers' strategies for managing the use and cost of biopharmaceuticals.
    Robinson JC
    Health Aff (Millwood); 2006; 25(5):1205-17. PubMed ID: 16966716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting serious about generics.
    Sipkoff M
    Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
    [No Abstract]   [Full Text] [Related]  

  • 8. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 9. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives. Options vs. limits: drug cost strategies reconsidered.
    Cunningham R
    Faulkner Grays Med Health; 1997 Sep; 51(38):suppl 4. PubMed ID: 10173171
    [No Abstract]   [Full Text] [Related]  

  • 11. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

  • 13. The pills that ate your profits.
    Meyer H
    Hosp Health Netw; 1998 Feb; 72(3):18-22. PubMed ID: 9483145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dangerous spin doctors: seven steps to protect yourself from deception in medical research.
    Hyman M
    Explore (NY); 2011; 7(2):63-5. PubMed ID: 21397865
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals & psychotropic drugs.
    Health Aff (Millwood); 2009; 28(3):723. PubMed ID: 19414880
    [No Abstract]   [Full Text] [Related]  

  • 16. Kaiser Permanente's prescription drug benefit.
    Levine S; Campen D; Millares M; Barrueta A
    Health Aff (Millwood); 2000; 19(2):185-90. PubMed ID: 10718032
    [No Abstract]   [Full Text] [Related]  

  • 17. Formularies tighten and physicians adapt.
    Lawrence J
    Manag Care; 1998 Mar; 7(3):23-6, 29-30. PubMed ID: 10177957
    [No Abstract]   [Full Text] [Related]  

  • 18. What you need to know about Medicare Part D.
    Consum Rep; 2006 Feb; 71(2):34-6. PubMed ID: 16509047
    [No Abstract]   [Full Text] [Related]  

  • 19. HMOs try formularies in effort to curb prescription costs.
    Feldman A
    Contract Healthc; 1988 Jul; ():33-5. PubMed ID: 10290628
    [No Abstract]   [Full Text] [Related]  

  • 20. MMA formulary design requires health plans to control costs.
    Sipkoff M
    Manag Care; 2005 Jun; 14(6):18, 20. PubMed ID: 16044883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.